Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 4Phase 1/2 3Phase 3 1

Status

Completed 29Active not recruiting 7Terminated 4Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 98pembrolizumab 87Gemcitabine 81Carboplatin 63fludarabine 62Nivolumab 57Cisplatin 54Paclitaxel 51Radiotherapy 50Docetaxel 50Rituximab 46Dexamethasone 42Lenalidomide 41Ipilimumab 38Azacitidine 35Etoposide 34Cytarabine 34Temozolomide 32Bevacizumab 32Radiation 29venetoclax 28Bortezomib 27Magnetic Resonance Spectroscopy 26Irinotecan 26atezolizumab 25Pemetrexed 25Oxaliplatin 24Capecitabine 24fludarabine phosphate 23Filgrastim 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Terminated × AZD 6244 × Clear all
NCT03833427 2024-11-07

MK-5618-001

Merck Sharp & Dohme LLC

Phase 1 Terminated
32 enrolled 17 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT01160926 2023-04-24

DREAMtherapy

The Christie NHS Foundation Trust

Phase 1 Terminated
31 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01134601 2021-12-01

A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
1 enrolled 7 charts
Gastrointestinal

Rectal Neoplasms

NCT01949870 2016-05-13

Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study

AstraZeneca

Phase 1 Terminated
6 enrolled 6 charts
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡